4 research outputs found
Recommended from our members
Device-Associated Infection Rate and Mortality in Intensive Care Units of 9 Colombian Hospitals : Findings of the International Nosocomial Infection Control Consortium
Q2Q1Artículo original349-356Objective.
To perform active targeted prospective surveillance to measure device-associated infection (DAI) rates, attributable mortality due to DAI, and the microbiological and antibiotic resistance profiles of infecting pathogens at 10 intensive care units (ICUs) in 9 hospitals in Colombia, all of which are members of the International Infection Control Consortium.
Methods.
We conducted prospective surveillance of healthcare-associated infection in 9 hospitals by using the definitions of the US Centers for Disease Control and Prevention National Nosocomial Surveillance System (NNIS). DAI rates were calculated as the number of infections per 100 ICU patients and per 1,000 device-days.
Results.
During the 3-year study, 2,172 patients hospitalized in an ICU for an aggregate duration of 14,603 days acquired 266 DAIs, for an overall DAI rate of 12.2%, or 18.2 DAIs per 1,000 patient-days. Central venous catheter (CVC)–related bloodstream infection (BSI) (47.4% of DAIs; 11.3 cases per 1,000 catheter-days) was the most common DAI, followed by ventilator-associated pneumonia (VAP) (32.3% of DAIs; 10.0 cases per 1,000 ventilator-days) and catheter-associated urinary tract infection (CAUTI) (20.3% of DAIs; 4.3 cases per 1,000 catheter-days). Overall, 65.4% of all Staphylococcus aureus infections were caused by methicillin-resistant strains; 40.0% of Enterobacteriaceae isolates were resistant to ceftriaxone and 28.3% were resistant to ceftazidime; and 40.0% of Pseudomonas aeruginosa isolates were resistant to fluoroquinolones, 50.0% were resistant to ceftazidime, 33.3% were resistant to piperacillin-tazobactam, and 19.0% were resistant to imipenem. The crude unadjusted attributable mortality was 16.9% among patients with VAP (relative risk [RR], 1.93; 95% confidence interval [CI], 1.24-3.00; P = .002); 18.5 among those with CVC-associated BSI (RR, 2.02; 95% CI, 1.42-2.87; P<.001); and 10.5% among those with CAUTI (RR, 1.58; 95% CI, 0.78-3.18; P = .19).
Conclusion.
The rates of DAI in the Colombian ICUs were lower than those published in some reports from other Latin American countries and were higher than those reported in US ICUs by the NNIS. These data show the need for more-effective infection control interventions in Colombia
Bacteriemia por Staphylococcus aureus resistente a la meticilina en la unidad de cuidados intensivos: revisión de los estudios de pronóstico Bacteremia due to methicillin-resistant Staphylococcus aureus in intensive care unit: of prognostic studies
Staphylococcus aureus es una de los principales causas de infección de pacientes en estado crítico. La información de vigilancia muestra 32,9 % de resistencia a la meticilina y una frecuencia de aislamiento como causante de infección de 12,15 % en las unidades de cuidados intensivos, especialmente infecciones del torrente sanguíneo. No se encontraron artículos de síntesis de de los datos sobre el impacto de la resistencia de esta bacteria en la mortalidad de los pacientes gravemente comprometidos. Esta revisión de la literatura resume los estudios de pronóstico sobre la infección del torrente sanguíneo por S. aureus resistente a meticilina (SARM) en pacientes de la unidad de cuidados intensivos. Se incluyeron los artículos que evaluaron la mortalidad por bacteriemias primarias o secundarias, comparándola con controles sensibles a la meticilina o infectados por otra bacteria. No se incluyeron estudios con bacteriemias polimicrobianas. De 387 referencias, seis estudios cumplieron los criterios de inclusión. Los datos disponibles no permiten generar una conclusión sobre la mortalidad relacionada con SARM en la unidad de cuidados intensivos. Los análisis bivariados muestran un incremento de la mortalidad, el cual tiende a desaparecer cuando se controla por otras variables, como el tratamiento inicial apropiado y la gravedad del cuadro clínico. La participación de este microorganismo en la mortalidad de pacientes de la unidad de cuidados intensivos y sus determinantes, permanecen aún sin explicar.Staphylococcus aureus is an important infectious pathogen in critically ill patients. Local surveillance shows its isolation as infectious causative pathogen at intensive care units in 12.15% of cases and a methicillin resistance rate of 32.9%, specially related with bloodstream infections. This review summarizes available prognosis studies related to methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections at intensive care unit (ICU). References with primary or secondary bacteremia patients compared with susceptible pathogen controls or different pathogen were included. Polymicrobial bacteremias were not included. 387 references were retrieved, only six studies met the inclusion criteria. The available evidence does not support a definitive conclusion about MRSA-related mortality in ICU. Increased mortality registered in bivariate analysis disappears when other covariates as appropriate initial therapy and baseline severity are adjusted. The involvement of this marker in ICU patient´s mortality and their prognosis determinants still remain unexplained
Tendencias de los fenotipos de resistencia bacteriana en hospitales públicos y privados de alta complejidad de Colombia Trends of bacterial resistance phenotypes in high-complexity public and private hospitals in Colombia
OBJETIVO: Describir y comparar las frecuencias de los fenotipos de resistencia bacteriana de microorganismos obtenidos de pacientes en unidades de cuidados intensivos (UCI) y otros servicios de hospitalización (no UCI) públicos y privados de alta complejidad de Colombia. MÉTODOS: Estudio observacional, analítico, retrospectivo y multicéntrico, en el cual se consolidaronlos registros de los aislamientos bacterianos y los fenotipos de resistencia bacteriana de los microorganismos obtenidos de pacientes atendidos en UCI y no UCI de 79 hospitales públicos y privados de alta complejidad en el período de enero de 2007 a diciembre de 2009. La información se analizó con el programa WHONET® versión 5.5 (OMS) de acuerdo con las recomendaciones del Instituto de Estándares Clínicos y de Laboratorio 2009 y se resumió en un formato de extracción de datos en Excel®. Se realizó un análisis descriptivo en el cual se calcularon proporciones. El análisis de tendencias se realizó mediante la prueba de correlación de rangos de Spearman. RESULTADOS: Las tendencias de los fenotipos de resistencia bacteriana de 2007 a 2009 muestran un comportamiento incremental en la proporción de Enterococcus faecium resistente a vancomicina, Klebsiella pneumoniae resistente a imipenem y a ciprofloxacina, Escherichia coli resistente a ceftazidima, y Enterobacter cloacae resistente a cefotaxima (ρ = 1, P < 0,01) y una disminución de la proporción de los fenotipos E. coli resistente a ciprofloxacina, K. pneumoniae resistente a ceftazidima, Staphylococcus aureus resistente a oxacilina, y Pseudomonas aeruginosa resistente a ceftazidima y a ciprofloxacina (ρ = -1, P < 0,01). CONCLUSIONES: El análisis de tendencias presentado en este estudio constituye la línea de base para el establecimiento de un subsistema nacional de vigilancia epidemiológica. Las tendencias observadas muestran que la resistencia bacteriana a los antimicrobianos en el ámbito hospitalario es un fenómeno dinámico en Colombia y son evidencia de la emergencia de los fenotipos Efavan y Kpnimp en los hospitales.<br>OBJECTIVE: Describe and compare the frequency of bacterial resistance phenotypes of microorganisms obtained from patients in intensive care units (ICU) and other (non-ICU) high-complexity public and private hospital services in Colombia. METHODS: A retrospective observational, analytical, multicenter study was conducted. The records from January 2007 to December 2009 on bacterial isolates and bacterial resistance phenotypes of microorganisms obtained from ICU and non-ICU patients in 79 high-complexity public and private hospitals were consolidated. The information was analyzed with the WHONET® 5.5 (WHO) software, following the 2009 recommendations of the Clinical and Laboratory Standards Institute, and summarized on an Excel® spreadsheet. A descriptive analysis with the calculation of proportions was performed. The trends were analyzed with Spearman rank correlation. RESULTS: The 2007-2009 trends for bacterial resistance phenotypes show increased percentages of vancomycin-resistant Enterococcus faecium, imipenem-resistant Klebsiella pneumoniae, ciprofloxacin-resistant K. pneumoniae, ceftazidime-resistant Escherichia coli and cefotaxime-resistant Enterobacter cloacae (r = 1, P < 0.01), and reduced percentages of ciprofloxacin-resistant E. coli, ceftazidime-resistant K. pneumoniae, oxacillin-resistant Staphylococcus aureus, ceftazidime-resistant Pseudomonas aeruginosa, and ciprofloxacin-resistant P. aeruginosa (r = -1, P < 0.01). CONCLUSIONS: The trend analysis presented in this study is the baseline for establishing a national epidemiological surveillance subsystem. The trends observed reveal that bacterial resistance to antimicrobial drugs in hospitals in Colombia is a dynamic phenomenon, with evidence of the emergence of vancomycin-resistant E. faecium and imipenem-resistant K. pneumoniae phenotypes in the hospitals